Activation of NF-κB-Inducing Kinase in Islet β Cells Causes β Cell Failure and Diabetes

Area of Science:

• Endocrinology
• Immunology
• Molecular Biology

Background:

• Islet beta cell death is a key factor in diabetes development.
• Nuclear factor kappa B (NF-κB)-inducing kinase (NIK) activation is linked to beta cell dysfunction in obesity.
• The precise role of NIK activation in diabetes pathogenesis is not fully understood.

Purpose of the Study:

• To investigate the pathological significance of NIK activation in pancreatic beta cells.
• To determine if NIK kinase activity is essential for beta cell death and diabetes development.

Main Methods:

• Generation of mice with beta cell-specific overexpression of NIK (β-NIK-OE).
• Administration of the NIK inhibitor B022.
• Induction of beta cell death using H2O2 and streptozotocin (STZ).
• Assessment of hyperglycemia, beta cell death, and insulitis.

Main Results:

• β-NIK-OE mice developed spontaneous diabetes, characterized by insulin deficiency, beta cell death, and insulitis.
• Inhibition of NIK kinase activity by B022 protected beta cells from NIK-, H2O2-, and STZ-induced death.
• B022 treatment ameliorated hyperglycemia in STZ-treated mice.

Conclusions:

• NIK activation plays a critical role in beta cell failure and diabetes.
• The kinase activity of NIK is essential for inducing islet inflammation, beta cell death, and diabetes.
• Inhibiting NIK kinase activity represents a potential therapeutic strategy for treating diabetes.